AbbVie
ABBV
ABBV
2,240 hedge funds and large institutions have $94.8B invested in AbbVie in 2019 Q4 according to their latest regulatory filings, with 326 funds opening new positions, 830 increasing their positions, 830 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,240
Holders Change
+239
Holders Change %
+11.94%
% of All Funds
44.23%
Holding in Top 10
113
Holding in Top 10 Change
+40
Holding in Top 10 Change %
+54.79%
% of All Funds
2.23%
New
326
Increased
830
Reduced
830
Closed
58
Calls
$1.91B
Puts
$2.37B
Net Calls
-$454M
Net Calls Change
-$338M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$736M |
| 2 |
JPMorgan Chase & Co
New York
|
+$401M |
| 3 |
Renaissance Technologies
New York
|
+$398M |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$306M |
| 5 |
Truist Financial
Charlotte,
North Carolina
|
+$291M |
Top Sellers
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$1.24B |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$576M |
| 3 |
BlackRock
New York
|
-$270M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$207M |
| 5 |
HSBC Holdings
London,
United Kingdom
|
-$144M |
